What LB Pharmaceuticals Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Nussbaum Ran | Director | Sep 12 | Open-market buy · P | +1,000,000 | $15.00 | +$15M | 1,411,681 |
| Nussbaum Ran | Director | Sep 12 | Derivative Conversion · C | +411,681 | — | — | 411,681 |
| Pontifax Management 4 G.p. (2015) Ltd. | 10% owner | Sep 12 | Open-market buy · P | +1,000,000 | $15.00 | +$15M | 1,411,681 |
| Pontifax Management 4 G.p. (2015) Ltd. | 10% owner | Sep 12 | Derivative Conversion · C | +411,681 | — | — | 411,681 |
| Deep Track Biotechnology Master Fund, Ltd. | 10% owner | Sep 12 | Open-market buy · P | +666,666 | $15.00 | +$10M | 666,666 |
| Deep Track Biotechnology Master Fund, Ltd. | 10% owner | Sep 12 | Open-market buy · P | +2,000,000 | $15.00 | +$30M | 2,686,138 |
| Deep Track Biotechnology Master Fund, Ltd. | 10% owner | Sep 12 | Derivative Conversion · C | +686,138 | — | — | 686,138 |
| Vida Ventures Gp III, L.l.c. | 10% owner | Sep 12 | Open-market buy · P | +332,566 | $15.00 | +$4.99M | 880,214 |
| Vida Ventures Gp III, L.l.c. | 10% owner | Sep 12 | Derivative Conversion · C | +1,262 | — | — | 1,262 |
| Vida Ventures Gp III, L.l.c. | 10% owner | Sep 12 | Derivative Conversion · C | +547,648 | — | — | 547,648 |
| Vida Ventures Gp III, L.l.c. | 10% owner | Sep 12 | Open-market buy · P | +767 | $15.00 | +$11.5K | 2,029 |
Loading...
